pentobarbital decreases levels of vandetanib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Prevent coadministration with strong CYP3A4 inducers; these medicine lessen exposure to vandetanib by approximately forty%.Barbiturates look to reinforce the metabolism of exogenous corticosteroids likely throughout the induction